Sever Pharma Solutions is a specialized CDMO focused on controlled release systems for highly potent drug products. We offer a comprehensive range of CDMO services, allowing us to support drug product development from start to finish. Our expertise includes Polymer-Based Delivery Systems, Highly Potent Compounds (up to OEB6), and DEA Controlled Substances (Schedule 3–5). Through close cross-functional collaboration, we ensure seamless transitions from early formulation development and scale-up to commercial supply.
Our organization integrates core business functions with strategic planning, operational excellence, and SHE, ensuring clear decisions and efficient execution. With headquarters and commercial manufacturing in Malmö, Sweden, and development and manufacturing operations in Putnam, CT, USA, we combine local expertise with a global perspective.
FREDRIK HULTENIUS
CEO
NIKLAS ELLERSTRÖM
Chief Financial Officer
WOUTER DE GRAAFF
Chief Scientific Officer
ULRIKE FOLEY
Global Head of BD and Marketing
STEFAN PETERSSON
Global Head of HR
LINDA REBERT
VP of Operations
MARIE SVENSSON
Global Director PMO
JAMES TURNER
General Manager for US Operations
NIKLAS LINDGREN
VP of Quality